Skip to main content
Log in

A potentially misleading finding at somatostatin receptor scintigraphy: Focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bombardieri E, Ambrosini V, Aktolun C, et al; Oncology Committee of the EANM. 111In-pentetreotide scintigraphy procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2010, 37: 1441–8.

    Article  PubMed  Google Scholar 

  2. Cascini GL, Cuccurullo V, Mansi L. The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology. Q J Nucl Med Mol Imaging 2010, 54: 24–36.

    PubMed  CAS  Google Scholar 

  3. Gibril F, Reynolds JC, Chen CC, et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med 1999, 40: 539–53.

    PubMed  CAS  Google Scholar 

  4. Klecker RJ, Cioc AM, Pozderac RV. Positive In-111 pentetreotide scintigraphy: pulmonary hamartoma. Clin Nucl Med 2001, 26: 251–2.

    Article  PubMed  CAS  Google Scholar 

  5. Servaes S, El-Haddad G, Zhuang H. Intense octreotide activity in a thrombus. Clin Nucl Med 2008, 33: 140–1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minutoli, F., Herberg, A., Sindoni, A. et al. A potentially misleading finding at somatostatin receptor scintigraphy: Focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions. J Endocrinol Invest 35, 708–709 (2012). https://doi.org/10.1007/BF03345801

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345801

Keywords

Navigation